These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10651746

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
    Halldin MU, Tylleskär K, Hagenäs L, Tuvemo T, Gustafsson J.
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
    [Abstract] [Full Text] [Related]

  • 7. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.
    Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM.
    Diabetes; 2002 Aug; 51(8):2629-36. PubMed ID: 12145180
    [Abstract] [Full Text] [Related]

  • 8. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics.
    Waldbillig RJ, Jones BE, Schoen TJ, Moshayedi P, Heidersbach S, Bitar MS, van Kuijk FJ, de Juan E, Kador P, Chader GJ.
    Curr Eye Res; 1994 Jul; 13(7):539-46. PubMed ID: 7523030
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria.
    Wedrychowicz A, Dziatkowiak H, Nazim J, Sztefko K.
    Horm Res; 2005 Jul; 63(5):245-51. PubMed ID: 15920342
    [Abstract] [Full Text] [Related]

  • 10. Diabetic retinopathy is associated with decreased serum levels of free IGF-I and changes of IGF-binding proteins.
    Feldmann B, Jehle PM, Mohan S, Lang GE, Lang GK, Brueckel J, Boehm BO.
    Growth Horm IGF Res; 2000 Feb; 10(1):53-9. PubMed ID: 10753593
    [Abstract] [Full Text] [Related]

  • 11. High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes.
    Bergen K, Brismar K, Tehrani S.
    Growth Horm IGF Res; 2016 Aug; 29():78-82. PubMed ID: 27400272
    [Abstract] [Full Text] [Related]

  • 12. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment.
    Carroll PV, Umpleby M, Alexander EL, Egel VA, Callison KV, Sönksen PH, Russell-Jones DL.
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):739-46. PubMed ID: 10209561
    [Abstract] [Full Text] [Related]

  • 13. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
    Bereket A, Lang CH, Blethen SL, Ng LC, Wilson TA.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
    [Abstract] [Full Text] [Related]

  • 14. IGF-I and diabetes in adolescence.
    Dunger DB, Acerini CL.
    Diabetes Metab; 1998 Apr; 24(2):101-7. PubMed ID: 9592633
    [Abstract] [Full Text] [Related]

  • 15. Microvascular permeability is increased in both types of diabetes and correlates differentially with serum levels of insulin-like growth factor I (IGF-I) and vascular endothelial growth factor (VEGF).
    Brausewetter F, Jehle PM, Jung MF, Boehm BO, Brueckel J, Hombach V, Osterhues HH.
    Horm Metab Res; 2001 Dec; 33(12):713-20. PubMed ID: 11753756
    [Abstract] [Full Text] [Related]

  • 16. Effects of cholinergic modulation on serum insulin-like growth factor-I and its binding proteins in normal and diabetic subjects.
    Ismail IS, Miell JP, Scanlon MF, Peters JR.
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):147-52. PubMed ID: 7535669
    [Abstract] [Full Text] [Related]

  • 17. The insulin-like growth factor system and Type 1 diabetic retinopathy during pregnancy.
    Loukovaara S, Immonen IJ, Koistinen R, Rutanen EM, Hiilesmaa V, Loukovaara M, Kaaja RJ.
    J Diabetes Complications; 2005 Feb; 19(5):297-304. PubMed ID: 16112506
    [Abstract] [Full Text] [Related]

  • 18. Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects.
    Gibson JM, Westwood M, Lauszus FF, Klebe JG, Flyvbjerg A, White A.
    Diabetes; 1999 Feb; 48(2):321-6. PubMed ID: 10334308
    [Abstract] [Full Text] [Related]

  • 19. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 20. [Decreased serum level of free bioavailable IGF-I in patients with diabetic retinopathy].
    Feldmann B, Lang GE, Arnavaz A, Jehle PM, Böhm BO, Lang GK.
    Ophthalmologe; 1999 May; 96(5):300-5. PubMed ID: 10414118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.